134 related articles for article (PubMed ID: 2977626)
21. Comparative study on nude mice isotope assay (NM-IA) and subrenal capsule assay (SRCA) sensitivity tests of anticancer agents.
Nishiyama M; Nosoh Y; Yamaguchi M; Hirabayashi N; Toge T; Niimoto M; Hattori T
Jpn J Surg; 1987 Mar; 17(2):99-103. PubMed ID: 3114529
[TBL] [Abstract][Full Text] [Related]
22. [A six-day subrenal capsule assay for predictive testing of primary human tumors].
Yokoyama E; Irimajiri N; Shirakabe M; Matsumoto M; Haneda J; Kusunoki T; Utsunomiya J
Gan To Kagaku Ryoho; 1988 Jan; 15(1):67-71. PubMed ID: 3337530
[TBL] [Abstract][Full Text] [Related]
23. Randomized controlled trial of the efficacy of adjuvant immunochemotherapy and adjuvant chemotherapy for colorectal cancer, using different combinations of the intracutaneous streptococcal preparation OK-432 and the oral pyrimidines 1-hexylcarbamoyl-5-fluorouracil and uracil/tegafur.
Watanabe M; Nishida O; Kunii Y; Kodaira S; Takahashi T; Tominaga T; Hojyo K; Kato T; Niimoto M; Kunitomo K; Isomoto H; Ohashi Y; Yasutomi M
Int J Clin Oncol; 2004 Apr; 9(2):98-106. PubMed ID: 15108041
[TBL] [Abstract][Full Text] [Related]
24. [A randomized controlled study to compare 1-hexylcarbamoyl-5-fluorouracil (HCFU) and 1-(2-tetrahydrofuryl)-5-fluorouracil (Tegafur) for the prevention of post-operative recurrence of bladder cancer].
Misaki T; Hisazumi H; Sakai A; Nakamura T; Kanda S; Mikawa I; Miyagi T; Katsumi T; Orito M; Kawaguchi K
Hinyokika Kiyo; 1985 Jul; 31(7):1233-41. PubMed ID: 3933287
[TBL] [Abstract][Full Text] [Related]
25. [In vivo chemosensitivity test for UFT and FT-207. II. Chemosensitivity test on human tumor xenografts transplanted in nude mice].
Niimi K; Nishiyama M; Hirabayashi N; Yamaguchi M; Nosoh Y; Wang DC; Toge T; Niimoto M; Hattori T
Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1281-5. PubMed ID: 3107479
[TBL] [Abstract][Full Text] [Related]
26. Modulation by l-leucovorin of 1-hexylcarbamoyl-5-fluorouracil antitumor activity on human gastric and colon carcinomas serially transplanted into nude mice.
Kubota T; Kase S; Furukawa T; Tanino H; Kuo TH; Saikawa Y; Nishibori H; Ishibiki K; Kitajima M; Mabuchi K
Anticancer Res; 1992; 12(5):1549-53. PubMed ID: 1444220
[TBL] [Abstract][Full Text] [Related]
27. Enhancement of the anti-tumor effect of 5'-deoxy-5-fluorouridine by transfection of thymidine phosphorylase gene into human colon cancer cells.
Kanyama H; Tomita N; Yamano T; Miyoshi Y; Ohue M; Fujiwara Y; Sekimoto M; Sakita I; Tamaki Y; Monden M
Jpn J Cancer Res; 1999 Apr; 90(4):454-9. PubMed ID: 10363585
[TBL] [Abstract][Full Text] [Related]
28. [Development of fluoropyrimidine derivatives].
Fujii S; Shirasaka T
Gan To Kagaku Ryoho; 1984 Nov; 11(11):2316-28. PubMed ID: 6238573
[TBL] [Abstract][Full Text] [Related]
29. [Experimental study of UFT in prostatic carcinoma (DU-145) in nude mice].
Kagawa S; Takigawa H; Aga Y; Kurokawa K
Gan To Kagaku Ryoho; 1986 Dec; 13(12):3408-12. PubMed ID: 3098182
[TBL] [Abstract][Full Text] [Related]
30. The role of additional chemotherapy with oral UFT in intravenous combination chemotherapy with cisplatin and 5-fluorouracil for human gastric cancer xenograft lines of well- and poorly- differentiated adenocarcinomas transplanted in nude mice.
Tseng CC; Nio Y; Tsubono M; Kawabata K; Masai Y; Hayashi H; Fukumoto M; Tobe T
Anticancer Res; 1992; 12(4):1295-9. PubMed ID: 1503424
[TBL] [Abstract][Full Text] [Related]
31. gamma-Hydroxybutyric acid and 5-fluorouracil, metabolites of UFT, inhibit the angiogenesis induced by vascular endothelial growth factor.
Basaki Y; Chikahisa L; Aoyagi K; Miyadera K; Yonekura K; Hashimoto A; Okabe S; Wierzba K; Yamada Y
Angiogenesis; 2001; 4(3):163-73. PubMed ID: 11911014
[TBL] [Abstract][Full Text] [Related]
32. General pharmacological properties of UFT, a new type of anti-cancer agent consisting of 1-(2-tetrahydrofuryl)-5-fluorouracil (FT) and uracil. I: Pharmacological analysis of the combined effect of FT and uracil.
Yamamoto J; Toide K; Haruno A; Yoshimura Y; Unemi N
Arzneimittelforschung; 1981; 31(8):1268-78. PubMed ID: 6794578
[TBL] [Abstract][Full Text] [Related]
33. Preclinical antitumor efficacy of S-1: a new oral formulation of 5-fluorouracil on human tumor xenografts.
Fukushima M; Satake H; Uchida J; Shimamoto Y; Kato T; Takechi T; Okabe H; Fujioka A; Nakano K; Ohshimo H; Takeda S; Shirasaka T
Int J Oncol; 1998 Oct; 13(4):693-8. PubMed ID: 9735397
[TBL] [Abstract][Full Text] [Related]
34. 1-Hexylcarbamoyl-5-fluorouracil is more cytostatic than 5-fluorouracil against human tumors in vitro.
Maehara Y; Kusumoto H; Anai H; Kusumoto T; Hiramoto Y; Sugimachi K
Eur J Cancer Clin Oncol; 1987 Oct; 23(10):1511-5. PubMed ID: 3678315
[TBL] [Abstract][Full Text] [Related]
35. [Evaluation of subrenal capsule assay (SRC) for clinical cancers].
Akao S; Iwami N; Oya M; Terada H; Sasaki K; Ishikawa H; Kiumi F
Gan To Kagaku Ryoho; 1996 Apr; 23(5):607-13. PubMed ID: 8678520
[TBL] [Abstract][Full Text] [Related]
36. [Study of tissue drug concentration of fluorinated pyrimidine anticancer drugs--comparison of 5'DFUR and UFT].
Fukamura T; Umeno T; Jyozaki H; Haruta J; Okamoto K; Hashimoto M; Arima S; Shimura H
Gan To Kagaku Ryoho; 1990 Sep; 17(9):1887-92. PubMed ID: 2144106
[TBL] [Abstract][Full Text] [Related]
37. [Relationship between the anti-metastatic effect of UFT and in vitro chemosensitivity to 5-FU in metastatic tumors from orthotopic implanted colon cancer in nude rats].
Ogata Y; Akagi Y; Nozoe Y; Sasatomi T; Miyagi Y; Nakagawa M; Matono K; Kobayashi H; Shirouzu K
Gan To Kagaku Ryoho; 2001 May; 28(5):655-60. PubMed ID: 11383214
[TBL] [Abstract][Full Text] [Related]
38. Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2'-tetrahydrofuryl)-5-fluorouracil.
Ho DH; Pazdur R; Covington W; Brown N; Huo YY; Lassere Y; Kuritani J
Clin Cancer Res; 1998 Sep; 4(9):2085-8. PubMed ID: 9748123
[TBL] [Abstract][Full Text] [Related]
39. Phase I and pharmacokinetic study of the oral fluoropyrimidine S-1 on a once-daily-for-28-day schedule in patients with advanced malignancies.
Chu QS; Hammond LA; Schwartz G; Ochoa L; Rha SY; Denis L; Molpus K; Roedig B; Letrent SP; Damle B; DeCillis AP; Rowinsky EK
Clin Cancer Res; 2004 Aug; 10(15):4913-21. PubMed ID: 15297391
[TBL] [Abstract][Full Text] [Related]
40. Prediction of individual tumor chemosensitivity in subrenal capsule assay.
Nishiyama M; Noso Y; Hirabayashi N; Yamaguchi M; Toge T; Niimoto M; Hattori T
Jpn J Surg; 1986 Jul; 16(4):257-61. PubMed ID: 3095577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
